Merck & Co (MRK)

Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Kenneth C. Frazier
Employees:
68,000
ONE MERCK DR, P O BOX 100, WHITEHOUSE STATION, NJ 08889-0100
9084231688

Merck & Co., Inc. engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, Alliances and Healthcare Services. The Pharmaceutical segment includes human health pharmaceutical and vaccine products marketed either directly by the company or through joint ventures. Its human health pharmaceutical products consist of therapeutic and preventive agents, generally sold by prescription, for the treatment of human disorders. The Animal Health segment discovers, develops, manufactures and markets animal health products, including vaccines, which it sells to veterinarians, distributors and animal producers. The Alliances segment includes revenue from the company relationship with AstraZeneca LP. The Healthcare Services segment provides services and solutions that focus on engagement, health analytics and clinical services to improve the value of care delivered to patients. The company was founded in 1970 and is headquartered in Kenilworth, NJ.

Data derived from most recent annual or quarterly report
Market Cap 224.887 Billion Shares Outstanding2.529 Billion Avg 30-day Volume 8.901 Million
P/E Ratio0.0 Dividend Yield0.0 EPS
Price to Revenue0.0 Debt to Equity0.4659 EBITDA9.982 Billion
Price to Book Value0.0 Operating Margin21.333 Enterprise Value3.574 Billion
Current Ratio1.932 EPS Growth0 Quick Ratio1.402
1 Yr BETA 0.2567 52-week High/Low 95.72 / 69.04 Profit Margin34.154
Operating Cash Flow Growth-48.4943 Altman Z-Score2.7009 Free Cash Flow to Firm 552.846 Million
Earnings Report2022-10-27

Are you looking for this stock instead?

View SEC Filings from MRK instead.

View recent insider trading info

Funds Holding MRK (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding MRK

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Events (8k)

  • 8-K: filed on 2022-07-28:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-04-28:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-04-21:
    Item 2.02: Results of Operations and Financial Condition
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-03-25:
    Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2021-12-10:
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2021-10-28:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2021-08-20:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2021-07-29:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2021-06-21:
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2021-06-03:
    Item 2.01: Completion of Acquisition or Disposition of Assets
    Item 9.01: Financial Statements and Exhibits
  • Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    none

    Open Market Sells (S)

    none

    Exercise Derivative Conversion (M)

    none

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    GUINDO CHIRFI CHIEF MARKETING OFFICER

    • Officer
    110,759 2022-08-03 2

    WILLIAMS DAVID MICHAEL EVP,CHIEF INFO&DIGITAL OFFICER

    • Officer
    26,382 2022-08-03 6

    ROMANELLI JOSEPH PRESIDENT, HUMAN HEALTH INT?L

    • Officer
    25,284 2022-07-18 1

    WENDELL PETER C

    • Director
    116,036 2022-06-30 5

    GLOCER THOMAS H

    • Director
    89,309 2022-06-30 5

    COE MARY ELLEN

    • Director
    16,178 2022-06-30 4

    SEIDMAN CHRISTINE E

    • Director
    9,972 2022-06-30 4

    RUSSO PATRICIA F

    • Director
    60,655 2022-05-27 1

    LAVIZZO-MOUREY RISA J

    • Director
    8,893 2022-05-27 1

    BAKER DOUGLAS M JR

    • Director
    3,364 2022-05-27 2

    CRAIG PAMELA J.

    • Director
    24,867 2022-05-27 1

    THULIN INGE G

    • Director
    16,619 2022-05-27 1

    WARDEN KATHY J

    • Director
    8,518 2022-05-27 1

    ROTHMAN PAUL

    • Director
    23,252 2022-05-27 1

    MAYO STEPHEN

    • Director
    5,398 2022-05-27 1

    MIZELL STEVEN EVP, CHIEF HR OFFICER

    • Officer
    80,921 2022-05-03 3

    DELUCA RICHARD R. EVP&PRES, MERCK ANIMAL HEALLTH

    • Officer
    194,386 2022-05-03 4

    KARACHUN RITA A SR. VP FINCE-GLOBAL CONTROLLER

    • Officer
    40,480 2022-05-03 5

    ZACHARY JENNIFER EVP, GENERAL COUNSEL

    • Officer
    112,095 2022-05-03 2

    LI DEAN Y EXECUTIVE VP & PRESIDENT, MRL

    • Officer
    16,458 2022-05-03 4

    LECOINTE-CEPHAS LISA SVP CHIEF ETHICS & COM OFFICER

    • Officer
    3,130 2022-05-03 3

    LITCHFIELD CAROLINE EVP & CFO

    • Officer
    27,426 2022-05-03 5

    KLOBUCHAR MICHAEL A EVP - CHIEF STRATEGY OFFICER

    • Officer
    43,846 2022-05-03 4

    OOSTHUIZEN JOHANNES JACOBUS SVP, U.S. MARKET

    • Officer
    14,054 2022-05-03 4

    GARAY ARPA SVP HUMAN HEALTH GLOBAL MKTG.

    • Officer
    1,461 2022-05-03 5

    FRAZIER KENNETH C EXECUTIVE CHAIR

    • Officer
    • Director
    710,665 2022-02-24 2

    DAVIS ROBERT M CEO & PRESIDENT

    • Officer
    • Director
    247,593 2022-02-24 1

    GERBERDING JULIE L. EVP, CHIEF PATIENT OFFICER

    • Officer
    48,712 2022-02-24 2

    CHATTOPADHYAY SANAT EXE V-P & PRES. MMD

    • Officer
    112,981 2022-02-24 2

    CLYBURN FRANK EVP & PRES ? HUMAN HEALTH

    • Officer
    215,818 2021-10-30 1

    DOWNING CRISTAL N CHIEF COMM. & PUBLIC AFRS OFCR

    • Officer
    0 2021-08-16 1

    BRUN LESLIE A

    • Director
    51,667 2021-05-28 0

    NALLY MICHAEL EVP, CHIEF MARKETING OFFICER

    • Officer
    21,390 2021-02-26 0

    FLEMING MICHAEL SVP CHIEF ETHICS & COM OFFICER

    • Officer
    10,283 2021-02-26 0

    CECH THOMAS R

    • Director
    100 2020-05-29 0

    WEEKS WENDELL P

    • Director
    100 2020-05-07 0

    PERLMUTTER ROGER M EXE V-P & PRES, MRL

    • Officer
    215,060 2020-05-01 0

    LAZARUS ROCHELLE B

    • Director
    6,351 2020-03-31 0

    SCHOLEFIELD JAMES H EVP,CHIEF INFO&DIGITAL OFFICER

    • Officer
    7,142 2019-10-30 0

    NOSEWORTHY JOHN H

    • Director
    100 2019-03-29 0

    SCHECHTER ADAM H EVP & PRES-GLOBAL HUMAN HEALTH

    • Officer
    55,406 2018-11-01 0

    WATSON ASHLEY SVP CHIEF ETHICS & COM OFFICER

    • Officer
    9,962 2018-10-31 0

    THOMPSON CRAIG B.

    • Director
    3,352 2018-05-25 0

    GRADDICK WEIR MIRIAN M EXE V-P, HR

    • Officer
    80,433 2018-05-04 0

    HOLSTON MICHAEL J EVP, GENERAL COUNSEL

    • Officer
    69,786 2018-02-27 0

    REPRESAS CARLOS E

    • Director
    11,500 2017-05-26 0

    KIDDER C ROBERT

    • Director
    10,339 2017-05-12 0

    AMBROSE ADELE D SR.V-P & CHIEF COMUNS OFFICER

    • Officer
    22,708 2017-05-05 0

    GOLESTANI CLARK EVP & CHIEF INFO OFFICER

    • Officer
    19,943 2016-08-10 0

    ROSENBLATT MICHAEL EXEC V-P & CHIEF MED OFFICER

    • Officer
    41,473 2016-05-10 0

    HARRISON WILLIAM B JR

    • Director
    16,400 2016-04-13 0

    DEESE WILLIE A EXE V-P & PRES. MMD

    • Officer
    134,478 2016-02-22 0

    KUHLIK BRUCE N EXE V-P & GEN COUNSEL

    • Officer
    150,432 2015-05-01 0

    HELLER BRIDGETTE P EXE.VP & PRES.CON.HLTH.CARE

    • Officer
    35,474 2014-05-09 0

    KELLOGG PETER N EXE V-P & CFO

    • Officer
    149,554 2014-02-24 0

    CANAN JOHN SR.V-P FINC-GLOBAL CONTROLLER

    • Officer
    16,956 2014-02-24 0

    DO CUONG V EVP & CHIEF STRATEGY OFFICER

    • Officer
    0 2013-05-06 0

    KIM PETER S EXE V-P & PRES, MRL

    • Officer
    190,957 2013-02-25 0

    BOWLES RICHARD S III EXE VP&CHIEF ETHICS & COMPLOFF

    • Officer
    77,545 2012-05-10 0

    SCALET J CHRIS EXE V-P GLOBAL SRVS & CIO

    • Officer
    83,041 2012-05-02 0

    TATLOCK ANNE M

    • Director
    1,114 2012-03-30 0

    KELLEY WILLAM N

    • Director
    4,311 2012-03-30 0

    GOLDSTONE STEVEN F

    • Director
    1,000 2012-03-30 0

    KOHAN RAUL E EXE VICE PRESIDENT

    • Officer
    No longer subject to file 2011-12-31 0

    SHENK THOMAS E

    • Director
    1,000 2011-05-27 0

    JACOBSON HARRY R

    • Director
    4,034 2011-05-27 0

    CLARK RICHARD T CHAIRMAN

    • Officer
    • Director
    257,538 2011-02-28 0

    TURNER MERVYN CHIEF STRATEGY OFFICER

    • Officer
    27,969 2011-02-28 0

    BARSHAY STANLEY F EXVP&PRESCONSHLTHCARE

    • Officer
    72,765 2010-03-05 0

    STAHL JACK L

    • Director
    No longer subject to file 2009-11-03 0

    VAN OORDT ROBERT FW

    • Director
    No longer subject to file 2009-11-03 0

    HASSAN FRED CHAIRMAN AND CEO

    • Officer
    • Director
    No longer subject to file 2009-11-03 0

    COX CARRIE SMITH EXECUTIVE VICE PRESIDENT

    • Officer
    No longer subject to file 2009-11-03 0

    SABATINO THOMAS J JR EXECUTIVE VICE PRESIDENT

    • Officer
    No longer subject to file 2009-11-03 0

    THIER SAMUEL O MD

    • Director
    No longer subject to file 2009-11-03 0

    KOEHLER STEVEN H VICE PRESIDENT AND CONTROLLER

    • Officer
    No longer subject to file 2009-11-03 0

    TURNER KATHRYN C

    • Director
    No longer subject to file 2009-11-03 0

    COLBERT CELIA A SR. V-P, SEC.& AST.GEN.COUNSEL

    • Officer
    No longer subject to file 2009-11-03 0

    WEINBACH ARTHUR F

    • Director
    No longer subject to file 2009-11-03 0

    PEREZ ANTONIO M

    • Director
    No longer subject to file 2009-11-03 0

    MCGRATH EUGENE R

    • Director
    No longer subject to file 2009-11-03 0

    CHEELEY C RON SENIOR VICE PRESIDENT

    • Officer
    No longer subject to file 2009-11-03 0

    SAUNDERS BRENT L SENIOR VICE PRESIDENT

    • Officer
    No longer subject to file 2009-11-03 0

    BERTOLINI ROBERT J EXECUTIVE VICE PRESIDENT

    • Officer
    No longer subject to file 2009-11-03 0

    COLLIGAN THOMAS J

    • Director
    No longer subject to file 2009-11-03 0

    KOESTLER THOMAS P EXECUTIVE VICE PRESIDENT

    • Officer
    No longer subject to file 2009-11-03 0

    OSCHMANN STEFAN PRESIDENT, EMEA & CANADA

    • Officer
    No longer subject to file 2009-11-03 0

    MCDONOUGH MARK E VICE PRESIDENT AND TREASURER

    • Officer
    No longer subject to file 2009-11-03 0

    QUEISSER LORI A. SENIOR VICE PRESIDENT

    • Officer
    No longer subject to file 2009-11-03 0

    BECHERER HANS W

    • Director
    No longer subject to file 2009-10-14 0

    MUNDY CARL E JR

    • Director
    No longer subject to file 2009-10-14 0

    MCGLYNN MARGARET G PRESIDENT, MV & ID

    • Officer
    64,673 2009-04-24 0

    LEDER PHILIP

    • Director
    No longer subject to file 2008-12-01 0

    COLE JOHNNETTA B

    • Director
    460 2008-04-30 0

    ANSTICE DAVID W EXEC.V-P, STRATEGY INITIATIVES

    • Officer
    156,917 2008-03-31 0

    YARNO WENDY L CHIEF MARKETING OFFICER

    • Officer
    36,144 2008-02-28 0

    KELMAR STEVEN B VICE PRESIDENT, PUBLIC AFFAIRS

    • Officer
    26,365 2007-09-01 0

    LEWENT JUDY C EXEC.V.P.& C.F.O.

    • Officer
    233,677 2007-08-07 0

    BOSSIDY LAWRENCE A

    • Director
    40,440 2007-02-06 0

    DORSA CAROLINE V.P. & TREASURER

    • Officer
    16,485 2007-01-15 0

    PICKETT CECIL B VICE PRESIDENT

    • Officer
    168,541 2006-08-25 0

    OSBORNE RICHARD DE J

    • Director
    78,335 2006-05-20 0

    LOESCHER PETER PRESIDENT, GLOBAL HUMAN HEALTH

    • Officer
    255,000 2006-05-05 0

    BOWEN WILLIAM G

    • Director
    54,167 2006-04-28 0

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed
    Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

    WILLIAMS DAVID MICHAEL - Officer EVP,CHIEF INFO&DIGITAL OFFICER

    2022-08-04 15:59:37 -0400 2022-08-03 A 17,119 a 17,119 direct

    GUINDO CHIRFI - Officer CHIEF MARKETING OFFICER

    2022-08-04 16:04:11 -0400 2022-08-03 A 110,705 a 110,705 direct

    WENDELL PETER C - Director

    2022-07-05 10:03:25 -0400 2022-06-30 A 329 $91.17 a 115,036 direct

    SEIDMAN CHRISTINE E - Director

    2022-07-05 10:05:15 -0400 2022-06-30 A 89 $91.17 a 9,872 direct

    GLOCER THOMAS H - Director

    2022-07-05 10:07:37 -0400 2022-06-30 A 494 $91.17 a 84,209 direct

    COE MARY ELLEN - Director

    2022-07-05 10:09:30 -0400 2022-06-30 A 356 $91.17 a 16,168 direct

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available
    MERCK & CO INC MRK 2022-08-12 19:15:05 UTC 2.07 0.25 0
    MERCK & CO INC MRK 2022-08-12 18:45:03 UTC 2.07 0.25 0
    MERCK & CO INC MRK 2022-08-12 18:15:04 UTC 2.07 0.25 0
    MERCK & CO INC MRK 2022-08-12 17:45:04 UTC 2.07 0.25 0
    MERCK & CO INC MRK 2022-08-12 17:15:05 UTC 2.07 0.25 0
    MERCK & CO INC MRK 2022-08-12 16:45:04 UTC 2.07 0.25 0
    MERCK & CO INC MRK 2022-08-12 16:15:04 UTC 2.07 0.25 0
    MERCK & CO INC MRK 2022-08-12 15:45:04 UTC 2.07 0.25 0
    MERCK & CO INC MRK 2022-08-12 15:15:05 UTC 2.07 0.25 0
    MERCK & CO INC MRK 2022-08-12 14:45:04 UTC 2.07 0.25 0
    MERCK & CO INC MRK 2022-08-12 14:15:05 UTC 2.07 0.25 0
    MERCK & CO INC MRK 2022-08-12 13:45:04 UTC 2.07 0.25 0
    MERCK & CO INC MRK 2022-08-12 13:15:04 UTC 2.07 0.25 0
    MERCK & CO INC MRK 2022-08-12 12:45:04 UTC 2.07 0.25 0
    MERCK & CO INC MRK 2022-08-11 22:15:03 UTC 2.07 0.25 0
    MERCK & CO INC MRK 2022-08-11 21:45:04 UTC 2.07 0.25 0
    MERCK & CO INC MRK 2022-08-11 21:15:03 UTC 2.07 0.25 0
    MERCK & CO INC MRK 2022-08-11 20:45:04 UTC 2.07 0.25 0
    MERCK & CO INC MRK 2022-08-11 20:15:03 UTC 2.07 0.25 0
    MERCK & CO INC MRK 2022-08-11 19:45:04 UTC 2.07 0.25 0

    Current Active Short Positions

    Holder Issuer Net Short Position Position Date Origin
    AGF Investments Trust- AGFIQ U.S. Market Neutral Momentum Fund MRK -296.0 shares, $-24212.8 2020-12-31 N-PORT
    M3Sixty Funds Trust- AXS Market Neutral Fund MRK -1167.0 shares, $-95460.6 2020-12-31 N-PORT
    JPMorgan Trust I- JPMorgan U.S. Large Cap Core Plus Fund MRK -60914.0 shares, $-4997993.7 2022-03-31 N-PORT
    JPMorgan Trust I- JPMorgan Research Market Neutral Fund MRK -9524.0 shares, $-844683.56 2022-04-30 N-PORT

    Elevate your investments